In December 2023, the Danish pharmaceutical company Novo Nordisk controlled more than half of the insulin market in China, in terms of sales volume. Founded in 1923, the firm specializes in producing diabetes medications, which accounted for around 80 percent of its annual sales revenue in 2023.
Market share of Novo Nordisk's medication sales in the diabetes care market in China in December 2023, by category
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Novo Nordisk. (March 7, 2024). Market share of Novo Nordisk's medication sales in the diabetes care market in China in December 2023, by category [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1122549/china-diabetes-care-market-share-of-novo-nordisk-by-product-type/
Novo Nordisk. "Market share of Novo Nordisk's medication sales in the diabetes care market in China in December 2023, by category." Chart. March 7, 2024. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1122549/china-diabetes-care-market-share-of-novo-nordisk-by-product-type/
Novo Nordisk. (2024). Market share of Novo Nordisk's medication sales in the diabetes care market in China in December 2023, by category. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1122549/china-diabetes-care-market-share-of-novo-nordisk-by-product-type/
Novo Nordisk. "Market Share of Novo Nordisk's Medication Sales in The Diabetes Care Market in China in December 2023, by Category." Statista, Statista Inc., 7 Mar 2024, https://www.statista.com/statistics/1122549/china-diabetes-care-market-share-of-novo-nordisk-by-product-type/
Novo Nordisk, Market share of Novo Nordisk's medication sales in the diabetes care market in China in December 2023, by category Statista, https://www.statista.com/statistics/1122549/china-diabetes-care-market-share-of-novo-nordisk-by-product-type/ (last visited November 21, 2024)
Market share of Novo Nordisk's medication sales in the diabetes care market in China in December 2023, by category [Graph], Novo Nordisk, March 7, 2024. [Online]. Available: https://www.statista.com/statistics/1122549/china-diabetes-care-market-share-of-novo-nordisk-by-product-type/